Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2477 of 5804
-
Mindfulness may help curb drug relapse, small study suggests
Disease control CompletedThis Interventional two-arm comparative study will evaluate whether a mindfulness-based strategy (MBS) improves outcomes for adults with substance use disorders (polydrug users) compared with treatment-as-usual (TAU). The primary question is whether MBS lowers cravings and reduce…
Phase: NA • Sponsor: Institute of Psychology, Chinese Academy of Sciences • Aim: Disease control
Last updated Jun 26, 2026 14:39 UTC
-
New study aims to find safe scabies treatment for toddlers
Knowledge-focused OngoingThis is an open label prospective pharmacokinetic single arm study in Laos PDR. This study will be embedded within a cluster-randomized controlled trial of interventions to address childhood undernutrition (SUANHOAM Trial, ACTRN12620000520932) and involves a collaboration with th…
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Paramedics at your doorstep: a new way to manage heart failure at home
Disease control Recruiting nowThe purpose of this research is to see if having community paramedic (CP) visit patients at home to manage their heart failure help them stay out of the hospital and improve their overall health compared to standard care. The investigators want to find out if their approach is be…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Virtual reality mirror therapy shows promise for stroke rehab
Symptom relief Recruiting nowIn the proposed study, the investigators assumed that Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Therapy (VRMCTOMT) will provide a better treatment effects than traditional virtual reality mirror therapy (VRMT) for the patients with unilateral stroke. The…
Phase: NA • Sponsor: National Cheng-Kung University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New bladder cancer cocktail aims to boost immune attack
Disease control TerminatedIn this study, we aim to evaluate the safety and efficacy of neoadjuvant combination using intravesical romidepsin and durvalumab in cisplatin-ineligible patients with muscle invasive bladder cancer (MIBC).
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New online therapy aims to ease brain tumor Patients' worst fears
Symptom relief Recruiting nowThe overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 26, 2026 14:38 UTC
-
Zapping the brain to beat insomnia: new study tests TMS for better sleep
Symptom relief Recruiting nowThe investigators propose to expand our previous work to test whether 10 repeated administrations of the cTBS procedure over a two-week period can lead to longer-term improvements in sleep, perhaps up to 3-months. For this 3-year study, 120 people with insomnia will be recruited …
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New Immune-Guiding drug takes on stubborn arthritis
Disease control Recruiting nowThe purpose of the study is to evaluate the safety and efficacy of BCMAxCD3 T-cell engager (cizutamig) in patients with refractory seropositive RA.
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Brain-Body combo training tested for stroke and moyamoya recovery
Knowledge-focused Recruiting nowThe following three-part proposal will explore the impact of applying motor-cognitive incorporated training (MCIT) in individuals with post-stroke cognitive impairment (PSCI) or Moyamoya disease (MMD), and examine the relationship between cognitive and motor impairments and brain…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Step up to fight dementia: new study tests tech support for seniors living alone
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn the effects of technology enhancements when combined with basic education, goal-setting, and self-monitoring to increase physical activity among older adults living alone, experiencing subjective cognitive decline, and currently engagin…
Phase: NA • Sponsor: Arizona State University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New combo device aims to keep patients breathing safely during lung scope
Symptom relief CompletedHypoxia represents the prevailing adverse occurrence during the sedation of patients undergoing fiberoptic bronchoscopy with propofol. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bit…
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a simple juice drink fight muscle loss in seniors?
Disease control Recruiting nowThis study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® sup…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
AI coach helps patients see their symptoms more clearly before doctor visit
Symptom relief OngoingThe goal of this clinical trial is to find out whether using an artificial intelligence (AI) tool called a Large Language Model (LLM) can help patients think more clearly about their symptoms and improve their trust and experience during a visit to a musculoskeletal specialist. …
Phase: NA • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New hope for tough lymphomas: experimental drug TLN-121 enters human testing
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety, pharmacokinetics,, and preliminary anti-tumor activity of TLN-121 as a single agent and in combination with other anti-lymphoma therapies in patients with relapsed or refractory Non-Hodgkin Lymphomas
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can smart alerts help ICU doctors catch problems faster?
Knowledge-focused OngoingAlerts related to outlier clinician behavior are generated in real-time by an intelligent system continuously scraping EHR (electronic health record) data. These alerts are passed to the bedside and their potential impact on bedside clinical behavior is evaluated.
Phase: NA • Sponsor: David T Huang • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can a common painkiller curb opiate use in the ICU?
Symptom relief Recruiting nowOpiates are commonly used to control pain in critically ill patients in the ICU. However, increased rates of opiate use in hospital may lead to increased prescription-based opiate dependence after leaving the ICU. This may contribute to the ongoing opiate epidemic across the worl…
Phase: PHASE3 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail targets metastatic colorectal cancer in early trial
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of CA-4948 when given together with fluorouracil, leucovorin, oxaliplatin (FOLFOX) plus bevacizumab in treating patients with colorectal cancer that has spread from where it first started (primary site) to other places in …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
One-Shot pain relief could replace pump for ankle surgery recovery
Symptom relief ENROLLING_BY_INVITATIONPostoperative pain remains undertreated. Opioids have well-known limitations for both individuals and society, and while single-injection peripheral nerve blocks with unencapsulated local anesthetic provide potent analgesia, their duration is measured in hours while post-surgical…
Phase: PHASE4 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New video program aims to ease the burden on FTD family caregivers
Symptom relief Recruiting nowThe purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New study investigates brain effects of CAR T-Cell therapy in young cancer patients
Knowledge-focused Recruiting nowBackground: CAR T-cell therapy is a promising new treatment for blood cancers. During treatment, a person s T-cells are genetically changed to kill cancer cells. Researchers want to learn more about the effects of potential problems that may be associated with this treatment. We…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC